Condition: Neurosurgical Patients · Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
To compare the performance of the Eleveld models for propofol and remifentanil on neurosurgery patients admitted to intensive care with their intraoperative performance.
This description comes directly from the study's public registry record.
Michele Introna, M.D. · 00390223942420 · michele.introna@istituto-besta.it
Marco Gemma, M.D. · 0039022394.2411 · marco.gemma@istituto-besta.it
Always discuss trial participation with your own doctor first.
| Foundation IRCCS Carlo Besta Neurological Institute | Milan, Italy, Italy | Recruiting |
| Fondazione IRCCS Istituto Neurologico C. Besta | Milan, Milano, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06584097